{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T16:33:07Z","timestamp":1759336387173,"version":"3.40.3"},"publisher-location":"New York, NY","reference-count":16,"publisher":"Springer US","isbn-type":[{"type":"print","value":"9781071627716"},{"type":"electronic","value":"9781071627723"}],"license":[{"start":{"date-parts":[[2022,11,19]],"date-time":"2022-11-19T00:00:00Z","timestamp":1668816000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2022,11,19]],"date-time":"2022-11-19T00:00:00Z","timestamp":1668816000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2023]]},"DOI":"10.1007\/978-1-0716-2772-3_24","type":"book-chapter","created":{"date-parts":[[2022,11,18]],"date-time":"2022-11-18T18:07:03Z","timestamp":1668794823000},"page":"467-478","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["Effects of Glucocorticoids in Murine Models of Duchenne and Limb-Girdle Muscular Dystrophy"],"prefix":"10.1007","author":[{"given":"Michelle","family":"Wintzinger","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Karen","family":"Miz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Allen","family":"York","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alexis R.","family":"Demonbreun","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jeffery D.","family":"Molkentin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elizabeth M.","family":"McNally","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mattia","family":"Quattrocelli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2022,11,19]]},"reference":[{"issue":"9307","key":"24_CR1","doi-asserted-by":"publisher","first-page":"687","DOI":"10.1016\/S0140-6736(02)07815-7","volume":"359","author":"AE Emery","year":"2002","unstructured":"Emery AE (2002) The muscular dystrophies. Lancet 359(9307):687\u2013695. https:\/\/doi.org\/10.1016\/S0140-6736(02)07815-7","journal-title":"Lancet"},{"issue":"4","key":"24_CR2","doi-asserted-by":"publisher","first-page":"1189","DOI":"10.1073\/pnas.81.4.1189","volume":"81","author":"G Bulfield","year":"1984","unstructured":"Bulfield G, Siller WG, Wight PA et al (1984) X chromosome-linked muscular dystrophy (mdx) in the mouse. Proc Natl Acad Sci U S A 81(4):1189\u20131192","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"5","key":"24_CR3","doi-asserted-by":"publisher","first-page":"1279","DOI":"10.1083\/jcb.142.5.1279","volume":"142","author":"AA Hack","year":"1998","unstructured":"Hack AA, Ly CT, Jiang F et al (1998) Gamma-sarcoglycan deficiency leads to muscle membrane defects and apoptosis independent of dystrophin. J Cell Biol 142(5):1279\u20131287","journal-title":"J Cell Biol"},{"issue":"1","key":"24_CR4","doi-asserted-by":"publisher","first-page":"14070","DOI":"10.1038\/s41598-020-70987-y","volume":"10","author":"DW Hammers","year":"2020","unstructured":"Hammers DW, Hart CC, Matheny MK et al (2020) The D2.mdx mouse as a preclinical model of the skeletal muscle pathology associated with Duchenne muscular dystrophy. Sci Rep 10(1):14070. https:\/\/doi.org\/10.1038\/s41598-020-70987-y","journal-title":"Sci Rep"},{"issue":"10119","key":"24_CR5","doi-asserted-by":"publisher","first-page":"451","DOI":"10.1016\/S0140-6736(17)32160-8","volume":"391","author":"CM McDonald","year":"2018","unstructured":"McDonald CM, Henricson EK, Abresch RT et al (2018) Long-term effects of glucocorticoids on function, quality of life, and survival in patients with Duchenne muscular dystrophy: a prospective cohort study. Lancet 391(10119):451\u2013461. https:\/\/doi.org\/10.1016\/S0140-6736(17)32160-8","journal-title":"Lancet"},{"key":"24_CR6","doi-asserted-by":"publisher","unstructured":"Quattrocelli M, Zelikovich AS, Salamone IM et al (2020) Mechanisms and clinical applications of glucocorticoid steroids in muscular dystrophy. J Neuromuscul Dis. https:\/\/doi.org\/10.3233\/JND-200556","DOI":"10.3233\/JND-200556"},{"key":"24_CR7","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1186\/1750-1172-8-26","volume":"8","author":"MC Walter","year":"2013","unstructured":"Walter MC, Reilich P, Thiele S et al (2013) Treatment of dysferlinopathy with deflazacort: a double-blind, placebo-controlled clinical trial. Orphanet J Rare Dis 8:26. https:\/\/doi.org\/10.1186\/1750-1172-8-26","journal-title":"Orphanet J Rare Dis"},{"issue":"11","key":"24_CR8","doi-asserted-by":"publisher","first-page":"2520","DOI":"10.1016\/j.ajpath.2017.07.017","volume":"187","author":"M Quattrocelli","year":"2017","unstructured":"Quattrocelli M, Salamone IM, Page PG et al (2017) Intermittent glucocorticoid dosing improves muscle repair and function in mice with limb-girdle muscular dystrophy. Am J Pathol 187(11):2520\u20132535. https:\/\/doi.org\/10.1016\/j.ajpath.2017.07.017","journal-title":"Am J Pathol"},{"issue":"6","key":"24_CR9","doi-asserted-by":"publisher","first-page":"2418","DOI":"10.1172\/JCI91445","volume":"127","author":"M Quattrocelli","year":"2017","unstructured":"Quattrocelli M, Barefield DY, Warner JL et al (2017) Intermittent glucocorticoid steroid dosing enhances muscle repair without eliciting muscle atrophy. J Clin Invest 127(6):2418\u20132432. https:\/\/doi.org\/10.1172\/JCI91445","journal-title":"J Clin Invest"},{"key":"24_CR10","doi-asserted-by":"publisher","unstructured":"Quattrocelli M, Zelikovich AS, Jiang Z et al (2019) Pulsed glucocorticoids enhance dystrophic muscle performance through epigenetic-metabolic reprogramming. JCI Insight 4(24). https:\/\/doi.org\/10.1172\/jci.insight.132402","DOI":"10.1172\/jci.insight.132402"},{"issue":"7378","key":"24_CR11","doi-asserted-by":"publisher","first-page":"552","DOI":"10.1038\/nature10700","volume":"480","author":"KA Lamia","year":"2011","unstructured":"Lamia KA, Papp SJ, Yu RT et al (2011) Cryptochromes mediate rhythmic repression of the glucocorticoid receptor. Nature 480(7378):552\u2013556. https:\/\/doi.org\/10.1038\/nature10700","journal-title":"Nature"},{"issue":"12","key":"24_CR12","doi-asserted-by":"publisher","first-page":"1954\u20131962 e1954","DOI":"10.1016\/j.cub.2019.04.073","volume":"29","author":"L Rizzini","year":"2019","unstructured":"Rizzini L, Levine DC, Perelis M et al (2019) Cryptochromes-mediated inhibition of the CRL4(Cop1)-complex assembly defines an evolutionary conserved signaling mechanism. Curr Biol 29(12):1954\u20131962 e1954. https:\/\/doi.org\/10.1016\/j.cub.2019.04.073","journal-title":"Curr Biol"},{"issue":"2","key":"24_CR13","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1002\/jmor.1052210207","volume":"221","author":"TJ Burkholder","year":"1994","unstructured":"Burkholder TJ, Fingado B, Baron S et al (1994) Relationship between muscle fiber types and sizes and muscle architectural properties in the mouse hindlimb. J Morphol 221(2):177\u2013190. https:\/\/doi.org\/10.1002\/jmor.1052210207","journal-title":"J Morphol"},{"key":"24_CR14","doi-asserted-by":"publisher","unstructured":"Carper D, Coue M, Laurens C et al (2020) Reappraisal of the optimal fasting time for insulin tolerance tests in mice. Mol Metab:101058. https:\/\/doi.org\/10.1016\/j.molmet.2020.101058","DOI":"10.1016\/j.molmet.2020.101058"},{"key":"24_CR15","doi-asserted-by":"publisher","DOI":"10.1155\/2015\/131436","volume":"2015","author":"NW Roberts","year":"2015","unstructured":"Roberts NW, Holley-Cuthrell J, Gonzalez-Vega M et al (2015) Biochemical and functional comparisons of mdx and Sgcg(-\/-) muscular dystrophy mouse models. Biomed Res Int 2015:131436. https:\/\/doi.org\/10.1155\/2015\/131436","journal-title":"Biomed Res Int"},{"issue":"4","key":"24_CR16","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0034204","volume":"7","author":"A Sali","year":"2012","unstructured":"Sali A, Guerron AD, Gordish-Dressman H et al (2012) Glucocorticoid-treated mice are an inappropriate positive control for long-term preclinical studies in the mdx mouse. PLoS One 7(4):e34204. https:\/\/doi.org\/10.1371\/journal.pone.0034204","journal-title":"PLoS One"}],"container-title":["Methods in Molecular Biology","Muscular Dystrophy Therapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/978-1-0716-2772-3_24","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,3,1]],"date-time":"2023-03-01T07:08:01Z","timestamp":1677654481000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/978-1-0716-2772-3_24"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,11,19]]},"ISBN":["9781071627716","9781071627723"],"references-count":16,"URL":"https:\/\/doi.org\/10.1007\/978-1-0716-2772-3_24","relation":{},"ISSN":["1064-3745","1940-6029"],"issn-type":[{"type":"print","value":"1064-3745"},{"type":"electronic","value":"1940-6029"}],"subject":[],"published":{"date-parts":[[2022,11,19]]},"assertion":[{"value":"19 November 2022","order":1,"name":"first_online","label":"First Online","group":{"name":"ChapterHistory","label":"Chapter History"}}]}}